|
1
|
Buchou T, Vernet M, Blond O, Jensen HH,
Pointu H, Olsen BB, Cochet C, Issinger OG and Boldyreff B:
Disruption of the regulatory beta subunit of protein kinase CK2 in
mice leads to a cell-autonomous defect and early embryonic
lethality. Mol Cell Biol. 23:908–915. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mountford PJ and Temperton DH:
Recommendations of the International Commission on Radiological
Protection (ICRP) 1990. Eur J Nucl Med. 19:77–79. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nyhan MJ, El Mashad SM, O'Donovan TR,
Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC and McKenna
SL: VHL genetic alteration in CCRCC does not determine
de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin. Cell Oncol
(Dordr). 34:225–234. 2011. View Article : Google Scholar
|
|
4
|
Grabmaier K, A de Weijert MC, Verhaegh GW,
Schalken JA and Oosterwijk E: Strict regulation of CAIX(G250/MN) by
HIF-1alpha in clear cell renal cell carcinoma. Oncogene.
23:5624–5631. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rini BI and Small EJ: Biology and clinical
development of vascular endothelial growth factor-targeted therapy
in renal cell carcinoma. J Clin Oncol. 23:1028–1043. 2005.
View Article : Google Scholar
|
|
6
|
Swietach P, Hulikova A, Vaughan-Jones RD
and Harris AL: New insights into the physiological role of carbonic
anhydrase IX in tumour pH regulation. Oncogene. 29:6509–6521. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kleinmann N, Duivenvoorden WC, Hopmans SN,
Beatty LK, Qiao S, Gallino D, Lhotak S, Daya D, Paschos A, Austin
RC, et al: Underactivation of the adiponectin-adiponectin receptor
1 axis in clear cell renal cell carcinoma: Implications for
progression. Clin Exp Metastasis. 31:169–183. 2014. View Article : Google Scholar
|
|
8
|
Akurathi V, Dubois L, Lieuwes NG, Chitneni
SK, Cleynhens BJ, Vullo D, Supuran CT, Verbruggen AM, Lambin P and
Bormans GM: Synthesis and biological evaluation of a 99mTc-labelled
sulfonamide conjugate for in vivo visualization of carbonic
anhydrase IX expression in tumor hypoxia. Nucl Med Biol.
37:557–564. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doyen J, Parks SK, Marcié S, Pouysségur J
and Chiche J: Knock-down of hypoxia-induced carbonic anhydrases IX
and XII radiosensitizes tumor cells by increasing intracellular
acidosis. Front Oncol. 2:1992012.
|
|
10
|
Ivanov S, Liao SY, Ivanova A,
Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ,
Proescholdt MA, Oldfield EH, Lee J, et al: Expression of
hypoxia-inducible cell-surface transmembrane carbonic anhydrases in
human cancer. Am J Pathol. 158:905–919. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Neuman MG, Shear NH, Malkiewicz IM, Taeri
M, Shapiro LE, Krivoy N, Haber J, Gomez M, Fish J, Cartotto R, et
al: Immunopathogenesis of hypersensitivity syndrome reactions to
sulfonamides. Transl Res. 149:243–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim TH, Somerville PJ and Freeman CR:
Unilateral radiation nephropathy - the long-term significance. Int
J Radiat Oncol Biol Phys. 10:2053–2059. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kjaer M, Frederiksen PL and Engelholm SA:
Postoperative radiotherapy in stage II and III renal
adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer
Study Group. Int J Radiat Oncol Biol Phys. 13:665–672. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kao GD, Malkowicz SB, Whittington R,
D'Amico AV and Wein AJ: Locally advanced renal cell carcinoma: Low
complication rate and efficacy of postnephrectomy radiation therapy
planned with CT. Radiology. 193:725–730. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Svedman C, Karlsson K, Rutkowska E,
Sandström P, Blomgren H, Lax I and Wersäll P: Stereotactic body
radiotherapy of primary and metastatic renal lesions for patients
with only one functioning kidney. Acta Oncol. 47:1578–1583. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hensley HH, Hannoun-Levi JM, Hachem P, Mu
Z, Stoyanova R, Khor LY, Agrawal S and Pollack A: PKA knockdown
enhances cell killing in response to radiation and androgen
deprivation. Int J Cancer. 128:962–973. 2011. View Article : Google Scholar
|
|
17
|
Barazzuol L, Jena R, Burnet NG, Jeynes JC,
Merchant MJ, Kirkby KJ and Kirkby NF: In vitro evaluation of
combined temozolomide and radiotherapy using X rays and high-linear
energy transfer radiation for glioblastoma. Radiat Res.
177:651–662. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
McIntyre A, Patiar S, Wigfield S, Li JL,
Ledaki I, Turley H, Leek R, Snell C, Gatter K, Sly WS, et al:
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo
and inhibition enhances anti-VEGF therapy. Clin Cancer Res.
18:3100–3111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cianchi F, Vinci MC, Supuran CT, Peruzzi
B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini
A, et al: Selective inhibition of carbonic anhydrase IX decreases
cell proliferation and induces ceramide-mediated apoptosis in human
cancer cells. J Pharmacol Exp Ther. 334:710–719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dubois L, Peeters S, Lieuwes NG, Geusens
N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogné
JM, et al: Specific inhibition of carbonic anhydrase IX activity
enhances the in vivo therapeutic effect of tumor irradiation.
Radiother Oncol. 99:424–431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuks Z and Kolesnick R: Engaging the
vascular component of the tumor response. Cancer Cell. 8:89–91.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Meerleer G, Khoo V, Escudier B, Joniau
S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N,
et al: Radiotherapy for renal-cell carcinoma. Lancet Oncol.
15:e170–e177. 2014. View Article : Google Scholar : PubMed/NCBI
|
